نوع مقاله : مقاله پژوهشی
نویسنده
دانشیار گروه مهندسی صنایع، دانشگاه سمنان، سمنان، ایران
چکیده
کلیدواژهها
عنوان مقاله [English]
نویسنده [English]
Background and Objectives: The selection of nanopharmaceutical suppliers plays a vital role in public health and treatment quality, directly affecting a company’s value chain. This study employs a fuzzy hybrid Analytical Hierarchy Process (AHP)–PROMSIS approach to evaluate and select nanopharmaceutical suppliers based on value chain factors.
Materials and Methods: First, the key criteria for evaluating and ranking suppliers in the nanopharmaceutical supply chain were identified, considering the elements of the value chain. The weights of these criteria were determined using the Analytical Hierarchy Process (AHP). Then, the performance score of each supplier under each criterion was assessed. Finally, supplier ranking was performed using the fuzzy PROMIS method.
Results: In this study, 32 criteria were identified and grouped into nine main categories, and their relationships with value chain elements were established. The results indicated that Quality and Compliance, Technical Capability and Innovation, and Safety and Risk were the most important categories, respectively. Moreover, the criteria Compliance with GMP and regulatory requirements, Ability to produce complex nanostructures, and International certifications were found to be the top three individual criteria. In addition, the final ranking of the suppliers was determined.
Conclusion: The findings revealed that the fuzzy hybrid AHP–PROMSIS approach is an effective tool for identifying and ranking suppliers in the nanopharmaceutical supply chain. Considering the comprehensive criteria developed for supplier evaluation not only enhances decision-making transparency but also leads to the optimal selection of suppliers and increased value creation in pharmaceutical organizations.
کلیدواژهها [English]
)